Drug Shortage Report for PREGABALIN
| Report ID | 28267 |
| Drug Identification Number | 02403692 |
| Brand name | PREGABALIN |
| Common or Proper name | PREGABALIN |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 25MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2017-10-11 |
| Estimated end date | 2017-12-22 |
| Actual end date | 2017-12-22 |
| Shortage status | Resolved |
| Updated date | 2018-01-18 |
| Company comments | Temporarily unavailable |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2018-01-18 | French | Compare |
| v5 | 2018-01-18 | English | Compare |
| v4 | 2017-12-12 | French | Compare |
| v3 | 2017-12-12 | English | Compare |
| v2 | 2017-11-06 | French | Compare |
| v1 | 2017-11-06 | English | Compare |
Showing 1 to 6 of 6